A clinical study of the timing of CRRT for abdominal infection complicated with acute kidney injury by plasma NGAL
-
摘要: 目的:探讨血浆中性粒细胞明胶酶相关脂质转运蛋白(pNGAL)水平对指导腹腔感染急性肾损伤(AKI)患者选择连续性肾脏替代治疗(CRRT)时机的作用。方法:将2016-01—2019-01期间我院外科ICU收治的80例腹腔感染并发AKI行CRRT的患者分为两组,pNGAL值为245~417 ng/mL的40例患者为pNGAL组;按常规行CRRT的40例患者为对照组。对比不同组别患者血管活性药物使用率、入ICU到开始CRRT时间、CRRT使用时间、机械通气时间、ICU住院时间、乳酸、降钙素原(PCT)、尿素氮(BUN)、pNGAL、肌酐(Cr)、尿量、急性生理与慢性健康状况评分(APACHEⅡ评分)、序贯器官衰竭评分(SOFA评分)并绘制生存曲线。结果:pNGAL组患者入ICU到开始CRRT时间、CRRT使用时间、机械通气时间及ICU住院时间较对照组缩短,差异有统计学意义(P<0.05)。行CRRT 0 h时,pNGAL组的PCT、BUN、pNGAL、Cr、APACHEⅡ评分和SOFA评分比对照组低,pNGAL组的尿量高于对照组,差异有统计学意义(P<0.05)。行CRRT 24 h及48 h后,两组的PCT、BUN、pNGAL、Cr和尿量较CRRT 0 h时明显改善(P<0.05);pNGAL组的PCT、BUN、pNGAL、Cr、APACHEⅡ评分和SOFA评分较对照组低,pNGAL组的尿量较对照组高,差异有统计学意义(P<0.05)。两组患者的生存分析显示,pNGAL组患者的28 d生存率较对照组高(P=0.023)。结论:pNGAL水平可用于指导腹腔感染并发AKI患者选择CRRT的时机,早期CRRT可提高患者28 d生存率。
-
关键词:
- 血浆中性粒细胞明胶酶相关脂质转运蛋白 /
- 腹腔感染 /
- 连续性肾脏替代治疗 /
- 急性肾损伤 /
- 治疗时机
Abstract: Objective:To explore the effect of plasma neutrophil gelatinase-associated lipocalin level on the timing of continuous renal replacement therapy in patients with acute renal injury caused by abdominal infection. Method:We selected 80 cases of abdominal cavity infection with acute kidney injury patients who were treated with CRRT in our hospital surgical ICU from January 2016 to January 2019. Patient with pNGAL ranging from 245 ng/mL to 417 ng/mL was categorized as pNGAL group(40 cases), while the others as conventional CRRT control group(40 cases). The utilization rate of vasoactive agents, time from ICU admission to CRRT, CRRT time, mechanical ventilation time, ICU stay and the changes of lactic acid, procalcitonin, blood urea nitrogen(BUN), pNGAL, creatinine(Cr), urine volume, parallel acute physiology and chronic health evaluation(APACHE Ⅱ score), sequential organ failure assessment score(SOFA score) were compared. Result:The time from ICU admission to CRRT, CRRT time, mechanical ventilation time and ICU stay are shorter in pNGAL group than those in control group, with statistically significant differences(P<0.05). When CRRT 0 h was performed, BUN, pNGAL, Cr, APACHEⅡ score and SOFA score in pNGAL group were lower than those in control group(P<0.05), while the urine volume of pNGAL group was significantly higher than that of control group(P<0.05). After CRRT 24 h and 48 h treatment, BUN, pNGAL, Cr, urine volume and APACHE Ⅱ scores in the two groups were significantly improved compared with that CRRT 0 h, with statistically significant difference(P<0.05). PCT, BUN, pNGAL, Cr, APACHE Ⅱ and SOFA scores in pNGAL group were lower than those in control group, with statistically significant difference(P<0.05), while the urine volume of pNGAL group was significantly higher than that of control group(P<0.05). The survival analysis of patients in the two groups showed that the 28-day survival rate was higher in the pNGAL group(P=0.023).Conclusion:For patients with abdominal infection complicated with acute kidney injury, the pNGAL level can be referred to select the timing of CRRT, and the early initiation of CRRT is beneficial to improve the 28-day survival rate. -
[1] Chertow GM,Burdick E,Honour M,et al.Acute kidney injury,mortality,length of stay,and costs in hospitalized patients[J].J Am Soc Nephrol,2005,16(11):3365-3370.
[2] Peters E,Antonelli M,Wittebole X,et al.A worldwide multicentre evaluation of the influence of deterioration or improvement of acute kidney injury on clinical outcome in critically ill patients with and without sepsis at ICU admission:results from The Intensive Care Over Nations audit[J].Crit Care,2018,22(1):188.
[3] Karvellas CJ,Farhat MR,Sajjad I,et al.A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury:a systematic review and meta-analysis[J].Crit Care(London,England),2011,15(1):R72.
[4] Ricci Z,Romagnoli S.Renal replacement therapy for critically ill patients:an intermittent continuity[J].Crit Care,2014,18(2):115.
[5] Mori K,Lee HT,Rapoport D,et al.Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury[J].J Clin Invest,2005,115(3):610-621.
[6] Aydogdu M,Boyaci N,Yuksel S,et al.A promising marker in early diagnosis of septic acute kidney injury of critically ill patients:urine insulin like growth factor binding protein-7[J].Scand J Clin Lab Invest,2016,76(5):402-410.
[7] Khawaja S,Jafri L,Siddiqui I,et al.The utility of neutrophil gelatinase-associated Lipocalin(NGAL)as a marker of acute kidney injury(AKI)in critically ill patients[J].Biomarker Res,2019,7(1):4.
[8] de Geus HR,Bakker J,Lesaffre EM,et al.Neutrophil Gelatinase-associated Lipocalin at ICU Admission Predicts for Acute Kidney Injury in Adult Patients[J].Am J Respir Crit Care Med,2011,183(7):907-914.
[9] Mehta RL,Kellum JA,Shah SV,et al.Acute Kidney Injury Network:report of an initiative to improve outcomes in acute kidney injury[J].Crit Care,2007,11(2):R31.
[10] 王大为,付研.连续性肾脏替代治疗[J].中国临床医生,2014,42(7):86-88.
[11] 刘昌,张靖垚.腹腔感染诊治新理念:共识与争议[J].中国实用外科杂志,2019,39(6):538-541.
[12] Uchino S,Kellum JA,Bellomo R,et al.Acute renal failure in critically ill patients:a multinational,multicenter study[J].JAMA,2005,294(7):813-818.
[13] Zhang J,Tian J,Sun H,et al.How Does Continuous Renal Replacement Therapy Affect Septic Acute Kidney Injury?[J].Blood Purif,2018,46(4):326-331.
[14] Liu KD,Himmelfarb J,Paganini E,et al.Timing of Initiation of Dialysis in Critically Ill Patients with Acute Kidney Injury[J].Clin J Am Soc Nephrol,2006,1(5):915-919.
[15] Khwaja A.KDIGO clinical practice guidelines for acute kidney injury[J].Nephron Clin Pract,2012,120(4):c179-c184.
[16] Kellum JA,Ronco C.The 17th Acute Disease Quality Initiative International Consensus Conference:Introducing Precision Renal Replacement Therapy[J].Blood Purif,2016,42(3):221-223.
[17] Jun M,Bellomo R,Cass A,et al.Timing of renal replacement therapy and patient outcomes in the randomized evaluation of normal versus augmented level of replacement therapy study[J].Crit Care Med,2014,42(8):1756-1765.
[18] Zarbock A,Kellum JA,Schmidt C,et al.Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury:The ELAIN Randomized Clinical Trial[J].JAMA,2016,315(20):2190-2199.
[19] Gaudry S,Hajage D,Schortgen F,et al.Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit[J].New Engl J Med,2016,375(2):122-133.
[20] Barbar SD,Clere-Jehl R,Bourredjem A,et al.Timing of Renal-Replacement Therapy in Patients with Acute Kidney Injury and Sepsis[J].N Engl J Med,2018,349(15):1431-1442.
[21] 吴颖,何再明.NGAL作为急性肾损伤生物标志物的研究现况[J].医学综述,2016,22(6):1058-1061.
[22] Mishra J,Dent C,Tarabishi R,et al.Neutrophil gelatinase-associated lipocalin(NGAL)as a biomarker for acute renal injury after cardiac surgery[J].Lancet,2005,365(9466):1231-1238.
[23] 赵仁淹,郑瑞强.中性粒细胞明胶酶相关脂质运载蛋白对感染性休克继发急性肾损伤患者的早期诊断价值[J].临床急诊杂志,2018,19(7):443-446.
[24] 罗俊华,吴娜,李娟.接受连续性肾脏替代治疗的老年急性肾损伤患者NGAL、KIM-1检测的意义[J].临床军医杂志,2014,42(11):1118-1121.
[25] Li WX,Chen HD,Wang XW,et al.Predictive value of RIFLE classification on prognosis of critically ill patients with acute kidney injury treated with continuous renal replacement therapy[J].Chin Med J(Engl),2009,122(9):1020-1025.
[26] Di Somma S,Magrini L,De Berardinis B,et al.Additive value of blood neutrophil gelatinase-associated lipocalin to clinical judgement in acute kidney injury diagnosis and mortality prediction in patients hospitalized from the emergency department[J].Crit Care,2013,17(1):R29.
计量
- 文章访问数: 145
- PDF下载数: 43
- 施引文献: 0